XML 26 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Segment Information
Segment Information
Management has concluded that Life Sciences, which is focused on growth in the medical end market, primarily in the orthopaedics and medical/surgical end markets; Mobile Solutions, which is focused on growth in the general industrial and automotive end markets; and Power Solutions, which is focused on growth in the electrical and aerospace and defense end markets, constitute our operating segments. Life Sciences, Mobile Solutions, and Power Solutions are considered operating segments as each engages in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance.
The following tables present results of operations by reportable segment.
 
Life
Sciences
 
Mobile
Solutions
 
Power
Solutions
 
Corporate
and
Consolidations
 
 
 
Total
Three Months Ended March 31, 2020
 
 
 
 
 
 
 
 
 
 
 
Net sales
$
84,048

 
$
69,884

 
$
46,401

 
$
(588
)
 
(a)
 
$
199,745

Goodwill impairment
146,757

 

 
92,942

 

 
 
 
239,699

Income (loss) from operations
(140,979
)
 
264

 
(90,334
)
 
(14,283
)
 
 
 
$
(245,332
)
Interest expense
 
 
 
 
 
 
 
 
 
 
(17,077
)
Other
 
 
 
 
 
 
 
 
 
 
(1,120
)
Loss before benefit for income taxes and share of net loss from joint venture
 
 
 
 
 
 
 
 
 
 
$
(263,529
)
Three Months Ended March 31, 2019
 
 
 
 
 
 
 
 
 
 
 
Net sales
$
86,008

 
$
78,075

 
$
49,657

 
$
(484
)
 
(a)
 
$
213,256

Income (loss) from operations
3,846

 
3,189

 
3,824

 
(11,176
)
 
 
 
$
(317
)
Interest expense
 
 
 
 
 
 
 
 
 
 
(13,801
)
Other
 
 
 
 
 
 
 
 
 
 
(3,428
)
Loss before provision for income taxes and share of net income from joint venture
 
 
 
 
 
 
 
 
 
 
$
(17,546
)
_______________________________

(a)
Includes elimination of intersegment transactions occurring during the ordinary course of business.

The following table presents total assets by reportable segment as of March 31, 2020, and December 31, 2019.
 
 
Total Assets
 
 
March 31, 2020
 
December 31, 2019
Life Sciences
 
$
648,603

 
$
811,526

Mobile Solutions
 
362,624

 
373,256

Power Solutions
 
214,602

 
310,545

Corporate and Consolidations
 
99,324

 
46,657

Total
 
$
1,325,153

 
$
1,541,984